Back
News
1 min read

EvoNexus Company, Edico Genome Gets $10 Million in Series A Financing

  • leilanifera
  • Author
    leilanifera
  • Published
    July 17, 2014
  1. Home
  2. News
  3. EvoNexus Company, Edico Genome Gets $10 Million in Series A Financing
Showing 1-1 of 1 results
Filter

Edico Genome, a San Diego bioinformatics chip maker, announced July 17 that it received $10 million in Series A venture funds.

Qualcomm Ventures led the round, joined by Axon Ventures. Greg Lucier, who was chairman and CEO of Life Technologies before it was sold to Thermo Fisher Scientific Inc., is investing in the company as an individual.

 

Next Post
EvoNexus Company, ScoreStream, Gets Ready for Some Football With $800,000 in Debt Funding

Recent Posts

FDA Grants Second Breakthrough Device Designation for EvoNexus Graduate Company, Carlsmed Technology

Read More

GigaIO, an EvoNexus Graduate, Launches Partnership with Climb Channel Solutions

Read More

EvoNexus Deep Dives Sign-Up

Get to know more about EvoNexus, Southern California’s most successful non-profit startup technology incubator! Throughout the 90 minute Deep Dive, you will learn more about:

  • EvoNexus' highly selective admission process
  • How we help with startup outreach
  • Unique EvoNexus incubation program benefits and discounts
  • Mentorship from world-class domain experts from some of the most well known technology companies
  • How EvoNexus helps your startup succeed and create a roadmap, exit, & more!

Fill out the contact form below to join the mailing list for Deep Dives.